Quoted from http://www.bloomberg.com/apps/news?pid=newsarchive&sid=a0QT8.Bt2Ud4
Wyeth Ordered to Unseal Prempro Ghostwriting Files
By Jef Feeley and Sonny Rhodes
July 24 (Bloomberg) -- Wyeth, the drugmaker being acquired by Pfizer Inc., was ordered by a federal judge to unseal files about its use of ghostwritten medical-journal articles to market menopause medicines.
U.S. District Judge William Wilson in Little Rock, Arkansas, today granted a request by PLoS Medicine, a medical journal, and the New York Times newspaper to have Wyeth make public documents about its ghostwriting practices in connection with the drugs Prempro and Premarin. Madison, New Jersey-based Wyeth faces claims from more than 10,000 women who contend the hormone-replacement medicines caused their breast cancers.
Drugmakers sometimes pay medical-communications companies to ghostwrite favorable studies of their products and then hire doctors to put their names on the journal articles. Many times, the drug company’s participation isn’t disclosed, lawyers for former Prempro users contend.